메뉴 건너뛰기




Volumn 11, Issue 1, 2013, Pages

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: A subgroup analysis of the EINSTEIN DVT and PE studies

Author keywords

Deep vein thrombosis; Pulmonary embolism; Randomized trial; Rivaroxaban; Venous thromboembolism; Vitamin K antagonist

Indexed keywords

ANTIVITAMIN K; CREATININE; ENOXAPARIN; RIVAROXABAN;

EID: 84890267947     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-11-25     Document Type: Article
Times cited : (25)

References (16)
  • 1
    • 0032559775 scopus 로고    scopus 로고
    • Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study
    • 10.1001/archinte.158.6.585, 9521222
    • Silverstein MD, Heit JA, Mohr DN, Petterson TM, OFallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998, 158:585-593. 10.1001/archinte.158.6.585, 9521222.
    • (1998) Arch Intern Med , vol.158 , pp. 585-593
    • Silverstein, M.D.1    Heit, J.A.2    Mohr, D.N.3    Petterson, T.M.4    O'Fallon, W.M.5    Melton, L.J.6
  • 2
    • 0034023924 scopus 로고    scopus 로고
    • Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d'Etude de la thrombose de Bretagne occidentale
    • Oger E. Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d'Etude de la thrombose de Bretagne occidentale. Thromb Haemost 2000, 83:657-660.
    • (2000) Thromb Haemost , vol.83 , pp. 657-660
    • Oger, E.1
  • 3
    • 0032507023 scopus 로고    scopus 로고
    • Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    • 10.1001/jama.279.6.458, 9466640
    • Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998, 279:458-462. 10.1001/jama.279.6.458, 9466640.
    • (1998) JAMA , vol.279 , pp. 458-462
    • Douketis, J.D.1    Kearon, C.2    Bates, S.3    Duku, E.K.4    Ginsberg, J.S.5
  • 4
    • 50549183274 scopus 로고
    • Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial
    • Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960, 1:1309-1312.
    • (1960) Lancet , vol.1 , pp. 1309-1312
    • Barritt, D.W.1    Jordan, S.C.2
  • 5
    • 84856802635 scopus 로고    scopus 로고
    • Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines
    • 3278049, 22315268
    • Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:e419S-e494S. 3278049, 22315268.
    • (2012) Chest , vol.141
    • Kearon, C.1    Akl, E.A.2    Comerota, A.J.3    Prandoni, P.4    Bounameaux, H.5    Goldhaber, S.Z.6    Nelson, M.E.7    Wells, P.S.8    Gould, M.K.9    Dentali, F.10    Crowther, M.11    Kahn, S.R.12
  • 7
    • 74249121331 scopus 로고    scopus 로고
    • Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects
    • Jiang J, Hu Y, Zhang J, Yang J, Mueck W, Kubitza D, Bauer RJ, Meng L, Hu P. Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects. Thromb Haemost 2010, 103:234-241.
    • (2010) Thromb Haemost , vol.103 , pp. 234-241
    • Jiang, J.1    Hu, Y.2    Zhang, J.3    Yang, J.4    Mueck, W.5    Kubitza, D.6    Bauer, R.J.7    Meng, L.8    Hu, P.9
  • 8
    • 78650619315 scopus 로고    scopus 로고
    • Oral rivaroxaban for symptomatic venous thromboembolism
    • The EINSTEIN Investigators
    • The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010, 363:2499-2510. The EINSTEIN Investigators.
    • (2010) N Engl J Med , vol.363 , pp. 2499-2510
  • 9
    • 84859385808 scopus 로고    scopus 로고
    • Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
    • The EINSTEIN-PE Investigators
    • The EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012, 366:1287-1297. The EINSTEIN-PE Investigators.
    • (2012) N Engl J Med , vol.366 , pp. 1287-1297
  • 10
    • 84879822413 scopus 로고    scopus 로고
    • Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
    • 10.1186/1477-9560-11-13, 3710481, 23829521
    • Prins MH, Lensing AWA. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thromb J 2013, 11:13. 10.1186/1477-9560-11-13, 3710481, 23829521.
    • (2013) Thromb J , vol.11 , pp. 13
    • Prins, M.H.1    Lensing, A.W.A.2
  • 11
    • 84884336961 scopus 로고    scopus 로고
    • Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
    • 10.1186/1477-9560-11-21, 3850944, 24053656, on behalf of the EINSTEIN Investigators
    • Prins MH, Lensing AWA, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. on behalf of the EINSTEIN Investigators Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J 2013, 11:21. 10.1186/1477-9560-11-21, 3850944, 24053656, on behalf of the EINSTEIN Investigators.
    • (2013) Thromb J , vol.11 , pp. 21
    • Prins, M.H.1    Lensing, A.W.A.2    Bauersachs, R.3    van Bellen, B.4    Bounameaux, H.5    Brighton, T.A.6    Cohen, A.T.7    Davidson, B.L.8    Decousus, H.9    Raskob, G.E.10    Berkowitz, S.D.11    Wells, P.S.12
  • 12
    • 33750474106 scopus 로고    scopus 로고
    • Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in Western populations
    • 10.1016/j.thromres.2005.12.014, 16460786
    • Leung V, Leung V, Lui W, Chan T, Wong RS, Cheng G. Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in Western populations. Thromb Res 2006, 118:763-764. 10.1016/j.thromres.2005.12.014, 16460786.
    • (2006) Thromb Res , vol.118 , pp. 763-764
    • Leung, V.1    Leung, V.2    Lui, W.3    Chan, T.4    Wong, R.S.5    Cheng, G.6
  • 13
    • 84875282368 scopus 로고    scopus 로고
    • Incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis
    • 3211080, 22084666
    • Cheng G, Chan C, Liu YT, Choy YF, Wong MM, Yeung PK, Ng KL, Tsang LS, Wong RS. Incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis. Thrombosis 2011, 2011:629383. 3211080, 22084666.
    • (2011) Thrombosis , vol.2011 , pp. 629383
    • Cheng, G.1    Chan, C.2    Liu, Y.T.3    Choy, Y.F.4    Wong, M.M.5    Yeung, P.K.6    Ng, K.L.7    Tsang, L.S.8    Wong, R.S.9
  • 14
    • 18244400400 scopus 로고    scopus 로고
    • Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
    • 10.1111/j.1365-2125.2005.02361.x, 1884850, 15842557
    • You JH, Chan FW, Wong RS, Cheng G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?. Br J Clin Pharmacol 2005, 59:582-587. 10.1111/j.1365-2125.2005.02361.x, 1884850, 15842557.
    • (2005) Br J Clin Pharmacol , vol.59 , pp. 582-587
    • You, J.H.1    Chan, F.W.2    Wong, R.S.3    Cheng, G.4
  • 15
    • 1942485404 scopus 로고    scopus 로고
    • Hemorrhagic complications of anticoagulant therapy in Chinese patients
    • Chan TY, Miu KY. Hemorrhagic complications of anticoagulant therapy in Chinese patients. J Chin Med Assoc 2004, 67:55-62.
    • (2004) J Chin Med Assoc , vol.67 , pp. 55-62
    • Chan, T.Y.1    Miu, K.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.